Praxis Precision Medicines (PRAX) has had the highest return between October 15, 2025 and February 2, 2026 by a mid-cap US stock, returning 496.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Praxis Precision Medicines (PRAX) | 10/15/2025 - 2/2/2026 | 496.73% |
Alumis (ALMS) | 10/15/2025 - 2/2/2026 | 427.1% |
Hycroft Mining (HYMC) | 10/15/2025 - 2/2/2026 | 364.55% |
Erasca (ERAS) | 10/15/2025 - 2/2/2026 | 332.51% |
Terns Pharmaceuticals (TERN) | 10/15/2025 - 2/2/2026 | 319.9% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 10/15/2025 - 2/2/2026 | 191.15% |
Vicor (VICR) | 10/15/2025 - 2/2/2026 | 188.83% |
PACS (PACS) | 10/15/2025 - 2/2/2026 | 162.32% |
Immunitybio (IBRX) | 10/15/2025 - 2/2/2026 | 149% |
Olema Pharmaceuticals (OLMA) | 10/15/2025 - 2/2/2026 | 141.84% |
Celcuity LLC (CELC) | 10/15/2025 - 2/2/2026 | 133.45% |
Cogent Biosciences (COGT) | 10/15/2025 - 2/2/2026 | 132.73% |
BBVA Banco Frances SA ADR (BBAR) | 10/15/2025 - 2/2/2026 | 112.16% |
Belite Bio Inc ADR (BLTE) | 10/15/2025 - 2/2/2026 | 111.25% |
Cidara Therapeutics (CDTX) | 10/15/2025 - 2/2/2026 | 101.33% |
Banco Macro SA B ADR (BMA) | 10/15/2025 - 2/2/2026 | 99.83% |
Liberty Oilfield Services (LBRT) | 10/15/2025 - 2/2/2026 | 99.65% |
Edgewise Therapeutics (EWTX) | 10/15/2025 - 2/2/2026 | 90.85% |
Arrowhead Pharmaceuticals (ARWR) | 10/15/2025 - 2/2/2026 | 90.36% |
Viavi Solutions (VIAV) | 10/15/2025 - 2/2/2026 | 88.73% |
Telecom Argentina SA ADR (TEO) | 10/15/2025 - 2/2/2026 | 84.92% |
Liquidia Technologies (LQDA) | 10/15/2025 - 2/2/2026 | 84.79% |
Victoria's Secret (VSCO) | 10/15/2025 - 2/2/2026 | 82.86% |
Amicus Therapeutics (FOLD) | 10/15/2025 - 2/2/2026 | 77.41% |
Immunome (IMNM) | 10/15/2025 - 2/2/2026 | 75.98% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
